IL1B and cancer: High levels of IL-1RA inhibit the signaling of IL-1β by competitively binding to IL-1 receptor, which reduce the risk of developing pancreatic disease, like via B cell-related immune pathways (5) and slower cancer cell growth (7) and migration (8).